Challenges and opportunities for applying quantum computers to drug design
ORAL
Abstract
The current limitations of classical computing methods in accurately describing quantum systems hinder the application of quantum chemistry to drug design. More precise computations could replace many labor-intensive experiments, provided the computational cost is lower. Quantum computations could offer key insights into chemical systems, justifying high computational costs in an industrial setting. However, to significantly impact the pharmaceutical industry, quantum computers must address a broader set of problems, including those involving large protein structures. New methods that balance accuracy and time on quantum computers could be beneficial. Significant advancements in hardware and quantum algorithms have reduced computational costs over the years, sparking optimism for the future use of quantum computing in quantum chemistry. However, harnessing the full potential of quantum computing in the pharmaceutical industry requires further improvements in hardware and novel algorithms. We will discuss these challenges and explore several potential routes to achieve these goals.
–
Publication: Santagati, R. et al. Drug design on quantum computers. Arxiv (2023) doi:10.48550/arxiv.2301.04114 https://arxiv.org/abs/2301.04114
Presenters
-
Raffaele Santagati
Boehringer-Ingelheim Quantum Lab, Boehringer Ingelheim
Authors
-
Raffaele Santagati
Boehringer-Ingelheim Quantum Lab, Boehringer Ingelheim
-
Alán Aspuru-Guzik
University of Toronto
-
Ryan Babbush
Google LLC, Google, Google Quantum AI
-
Matthias Degroote
Boehringer Ingelheim Pharm Inc
-
Leticia Gonzalez
University of Vienna
-
Elica Kyoseva
Boehringer-Ingelheim
-
Nikolaj Moll
Boehringer Ingelheim
-
Markus Oppel
University of Vienna
-
Robert M Parrish
QC WARE, QC Ware Cooperation, QC Ware, QC Ware Corporation
-
Nicholas C Rubin
Google, Google Quantum AI
-
Michael Streif
Boehringer Ingelheim, Boehringer Ingelheim Quantum Lab
-
Christofer Tautermann
Boehringer Ingelheim
-
Horst Weiss
BASF
-
Horst Weiss
BASF
-
Nathan Wiebe
University of Toronto
-
Clemens Utschig-Utschig
Boehringer Ingelheim